Oscar Health (NYSE:OSCR) CEO Mark Bertolini Sells 591,168 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR) CEO Mark Bertolini sold 591,168 shares of the business’s stock in a transaction on Friday, June 26th. The stock was sold at an average price of $29.28, for a total transaction of $17,309,399.04. Following the completion of the sale, the chief executive officer directly owned 8,990,566 shares of the company’s stock, valued at $263,243,772.48. This represents a 6.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Trading Down 1.4%

Shares of OSCR traded down $0.42 during trading hours on Monday, hitting $29.37. The company had a trading volume of 5,787,135 shares, compared to its average volume of 7,824,008. The stock’s 50 day moving average price is $23.03 and its 200 day moving average price is $17.37. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 52-week low of $10.69 and a 52-week high of $30.66. The firm has a market cap of $8.85 billion, a P/E ratio of -49.78, a P/E/G ratio of 2.08 and a beta of 2.37.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The firm had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. During the same quarter in the previous year, the company posted $0.92 earnings per share. The business’s revenue was up 52.6% on a year-over-year basis. On average, research analysts predict that Oscar Health, Inc. will post 0.47 EPS for the current year.

Analyst Ratings Changes

OSCR has been the subject of several recent analyst reports. Barclays raised shares of Oscar Health from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $30.00 to $35.00 in a research note on Wednesday, June 10th. Robert W. Baird increased their price objective on Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Zacks Research lowered Oscar Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 5th. Jefferies Financial Group raised Oscar Health from an “underperform” rating to a “hold” rating and boosted their target price for the company from $10.00 to $16.00 in a research note on Monday, April 20th. Finally, Wolfe Research initiated coverage on Oscar Health in a report on Tuesday, May 5th. They set a “peer perform” rating for the company. Three investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Oscar Health presently has a consensus rating of “Hold” and an average target price of $20.78.

Hedge Funds Weigh In On Oscar Health

A number of institutional investors have recently added to or reduced their stakes in the company. Jones Financial Companies Lllp lifted its position in Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after buying an additional 2,242 shares during the period. Strs Ohio bought a new stake in shares of Oscar Health during the 1st quarter valued at $30,000. Fifth Third Bancorp grew its position in shares of Oscar Health by 148.7% in the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after buying an additional 1,413 shares during the period. Quarry LP grew its position in shares of Oscar Health by 439.8% in the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after buying an additional 1,469 shares during the period. Finally, Harel Insurance Investments & Financial Services Ltd. purchased a new position in Oscar Health during the 1st quarter valued at about $49,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.